Tumor
“Progressing tumor”, “positive results”: patients are often confused by medical jargon
By Amy Norton HealthDay Reporter (Health Day) FRIDAY, Dec. 2, 2022 (HealthDay News) — If you’ve ever left a doctor’s appointment confused, it’s probably not you: Medical jargon used by doctors can be completely misunderstood by patients, a new study finds. Common medical jargon that makes perfect sense to doctors often gets lost in translation …
“Progressing tumor”, “positive results”: patients are often confused by medical jargon Read More »
Adding Tumor Lysate-Loaded Autologous Dendritic Cell Vaccination to Standard of Care Associated with Clinically Improved Overall Survival in Patients With Newly Diagnosed and Recurrent Glioblastoma | Medicine in 2 Minutes
1. In this phase 3 non-randomized controlled trial, among 331 patients, patients with newly diagnosed glioblastoma (nGBM) receiving dendritic cell vaccination (DCVax-L) had a median overall survival of 19.3 months versus 16.5 months in outpatient control patients treated with standard of care. 2. Patients with recurrent glioblastoma (rGBM) had a median overall survival of 13.2 …